Net gamma exposure for Edwards Lifesciences Corp (EW) options was positive at the Nov 4, 2026 close, about $7.42M per 1% move in the stock. It has been positive on 20 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for EW, 2026-11-20(m), calls & puts
Gamma Exposure Stats
Showing results for EW, 2026-11-20(m), calls & puts
Net Gamma Exposure by Expiration
Showing results for EW, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
EW Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is EW gamma exposure positive or negative?
Edwards Lifesciences net gamma exposure was positive on Nov 4, 2026, at $7.42M. It has been positive on 20 of the last 20 trading days.
How has EW gamma exposure changed recently?
Edwards Lifesciences net gamma exposure went from $990.83K on Oct 7, 2026 to $7.42M on Nov 4, 2026. That is its highest reading in 12 weeks. See the EW gamma exposure history for a longer view.
What is Edwards Lifesciences Corp?
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease.